Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Researchers dig into Real-World data to see how CTCL is actually treated

NCT ID NCT06588868

Knowledge-focused Sponsor: Fondazione Italiana Linfomi - ETS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks back at medical records of 400 adults with cutaneous T-cell lymphoma (CTCL) to see which systemic therapies doctors actually use and in what order. It aims to describe real-world treatment patterns, not test a new drug. The results may help guide future treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients affected by Cutaneous T-cell Lymphoma who have received first dose of a systemic therapy, lasted at least 3 months, between 1 January 2016 and 31 December 2021 in real life settings

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed diagnosis of CTCL according to the EORTC 2017 update criteria1. * Age ≥18 years. * Have received first dose of a systemic therapy, lasted at least 3 months, between 1 January 2016 and 31 December 2023. * Availability of complete medical records in order to provide protocol required variables * Signed written informed consent. Exclusion Criteria: * Patients not meeting the above-mentioned inclusion criteria. * Refuse to sign a written informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cutaneous T-cell lymphoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

mycosis fungoides primary cutaneous T-cell non-Hodgkin lymphoma Sezary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cutaneous T-cell lymphoma Cutaneous T-cell lymphoma/mycosis fungoides Cutaneous T-cell lymphoma/sezary syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O. Brotzu Ospedale Businco - S.C. Ematologia e CTMO

    NOT_YET_RECRUITING

    Cagliari, Italy

  • A.O.U. Città della Salute e della Scienza di Torino - S.C. Dermatologia U

    RECRUITING

    Torino, Italy

  • A.O.U. Policlinico S. Marco - U.O.C. di Ematologia

    NOT_YET_RECRUITING

    Catania, Italy

  • A.O.U.I. di Verona - U.O.C. Ematologia

    RECRUITING

    Verona, Italy

  • AOU Ospedali Riuniti delle Marche - Clinica di Ematologia

    RECRUITING

    Ancona, Italy

  • ASST Spedali Civili di Brescia - S.C. Ematologia

    NOT_YET_RECRUITING

    Brescia, Italy

  • IRCCS I.F.O. San Gallicano - UOSD Porfirie e Malattie Rare

    RECRUITING

    Roma, Italy

  • IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia

    RECRUITING

    Bari, Italy

  • Oncoematologia - ASST Fatebenefratelli - Sacco

    NOT_YET_RECRUITING

    Milan, Italy

  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia

    RECRUITING

    Bologna, Italy

  • S.C. Dermatologia - E.O. Galliera

    RECRUITING

    Genova, Italy

  • Skin Cancer Center - IRCCS Istituto Dermopatico dell'Immacolata

    NOT_YET_RECRUITING

    Roma, Italy

  • U.O.C Ematologia 1 - IRCCS Fondazione Policlinico San Matteo

    NOT_YET_RECRUITING

    Pavia, Italy

  • U.O.C. Clinica Dermatologica - A.O.U. di Padova

    NOT_YET_RECRUITING

    Padova, Italy

  • U.O.C. Dermatologia - A.O.U. Senese

    NOT_YET_RECRUITING

    Siena, Italy

  • U.O.C. Dermatologia - Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda

    RECRUITING

    Milan, Italy

  • U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale

    NOT_YET_RECRUITING

    Bari, Italy

  • Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi

    RECRUITING

    Florence, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.